Source: UniDoc Health.
  • UniDoc Health (UDOC) began trading on the CSE at today’s market open
  • The telehealth company’s primary offering is its Virtual Care Model, a physical pod that integrates online and offline products, as well as access to health care professionals
  • The company plans to commercialize the solution imminently
  • UniDoc is developing a self-contained remote virtual clinic that mimics a physician’s office
  • UniDoc Health (UDOC) closed up by 6.34 per cent trading at $1.51 per share

UniDoc Health (UDOC) began trading on the CSE at today’s market open.

The telehealth company’s primary offering is its Virtual Care Model, a customizable pod that integrates physical products, web-based services and analytical tools, as well as access to a developing network of health care providers, pharmacies and hospitals.

“Today’s news is immensely gratifying to the entire team,” said Antonio Baldassarre, UniDoc’s CEO. “The commencement of trading is the next step for the company’s development and anticipated commercialization of its innovative telehealth platform. With access to the public markets, UniDoc gains a broader audience which has the potential to better support the growth of the company through investment.”

“For our part,” he added, “we are dedicated to executing our strategic plan to unlock shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe.”

UniDoc is developing a self-contained remote virtual clinic that mimics a physician’s office. Its target market includes those challenged by access, experience or understanding of online computer technology.

UniDoc Health (UDOC) closed up by 6.34 per cent trading at $1.51 per share.

More From The Market Online

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.

BlackBerry expands AI-powered cybersecurity service

BlackBerry (TSX:BB) releases the new and expanded CylanceMDR, a managed detection and response tool backed by its Cylance AI platform.

Qualcomm stock jumps on Q2 2024 earnings

Qualcomm (NDAQ:QCOM) shares rise nearly 10 per cent early Thursday on better-than-expected adjusted earnings and strong revenue guidance.

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.